{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:17:55Z","timestamp":1772101075084,"version":"3.50.1"},"reference-count":54,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202466010","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:59:33Z","timestamp":1707127173000},"source":"Crossref","is-referenced-by-count":5,"title":["Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review"],"prefix":"10.1590","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-9526","authenticated-orcid":false,"given":"Noemia Barbosa","family":"Carvalho","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1112-081X","authenticated-orcid":false,"given":"Vera L\u00facia Teixeira de","family":"Freitas","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-3588","authenticated-orcid":false,"given":"Fernanda Salles","family":"Seguro","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6162-9852","authenticated-orcid":false,"given":"Rita Cristina","family":"Bezerra","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-049X","authenticated-orcid":false,"given":"Giancarlo","family":"Fatobene","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-385X","authenticated-orcid":false,"given":"\u00c9rika Yoshie Shimoda","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6537-0295","authenticated-orcid":false,"given":"Helena","family":"Visnadi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-2760","authenticated-orcid":false,"given":"Gracia","family":"Martinez","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-0873","authenticated-orcid":false,"given":"Marjorie Vieira","family":"Batista","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; AC Camargo Cancer Center,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0094-619X","authenticated-orcid":false,"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3256-5591","authenticated-orcid":false,"given":"Frederico Luis","family":"Dulley","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-752X","authenticated-orcid":false,"given":"S\u00edlvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-041X","authenticated-orcid":false,"given":"Maria Aparecida","family":"Shikanai-Yasuda","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.606368","article-title":"Harnessing the immune system against multiple myeloma: challenges and opportunities","volume":"10","author":"Yamamoto L","year":"2021","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040988","article-title":"Challenges for immunotherapy in multiple myeloma: bone marrow microenvironment-mediated immune suppression and immune resistance","volume":"12","author":"Holthof LC","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111432","article-title":"Biological background of resistance to current standards of care in multiple myeloma","volume":"8","author":"Mogoll\u00f3n P","year":"2019","journal-title":"Cells"},{"key":"ref4","first-page":"392","article-title":"Cellular immunotherapy in multiple myeloma: lessons from preclinical models","volume":"1846","author":"Binsfeld M","year":"2014","journal-title":"Biochem Biophys Acta"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164090","article-title":"The impact of induction regimes on immune responses in patients with multiple myeloma","volume":"13","author":"Firer MA","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.1401894","article-title":"Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T Cells","volume":"194","author":"Lu X","year":"2015","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091841","article-title":"Treatment of multiple myeloma and the role of melphalan in the era of modern therapies: current research and clinical approaches","volume":"10","author":"Poczta A","year":"2021","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40265-017-0689-1","article-title":"Immunomodulatory drugs in multiple myeloma: mechanisms of action and clinical experience","volume":"77","author":"Holstein SA","year":"2017","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/cbt.4.1.1379","article-title":"The proteasome inhibitor Bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells","volume":"4","author":"Matta H","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(19)31240-1","article-title":"Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study","volume":"394","author":"Moreau P","year":"2019","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1505654","article-title":"Elotuzumab therapy for relapsed or refractory multiple myeloma","volume":"373","author":"Lonial S","year":"2015","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","article-title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","volume":"21","author":"Lonial S","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau P","year":"2022","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja JG","year":"2021","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/j.clml.2020.12.026","article-title":"Efficacy of intravenous immunoglobulin for preventing infections in patients with multiple myeloma","volume":"21","author":"Lancman G","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bmt.1701107","article-title":"Recipients and donors of bone marrow transplants suffering from Chagas\u2019 disease: management and preemptive therapy of parasitemia","volume":"21","author":"Dictar M","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.bmt.1705006","article-title":"Chagas disease in bone marrow transplantation: an approach to preemptive therapy","volume":"36","author":"Altclas J","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001965","article-title":"Immunosuppression and Chagas disease: a management challenge","volume":"7","author":"Pinazo MJ","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7705\/biomedica.6288","article-title":"Reactivaci\u00f3n de la enfermedad de Chagas despu\u00e9s de trasplante aut\u00f3logo de progenitores hematopoy\u00e9ticos: reporte de caso y revisi\u00f3n de la literatura","volume":"42","author":"Rojas JD","year":"2022","journal-title":"Biomedica"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"E264","DOI":"10.1111\/tid.12157","article-title":"Reactivation of Chagas disease in a bone marrow transplant patient: case report and review of screening and management","volume":"15","author":"Guiang KM","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/cid\/ciy058","article-title":"The first case of Trypanosoma cruzi\u2013associated retinitis in an immunocompromised host diagnosed with pan-organism polymerase chain reaction","volume":"67","author":"Conrady CD","year":"2018","journal-title":"Clin Inf Dis"},{"key":"ref23","series-title":"Chagas disease"},{"issue":"Suppl 1","key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/0037-8682-0505-2016","article-title":"2nd Brazilian Consensus on Chagas Disease, 2015","volume":"49","author":"Dias JC","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref25","series-title":"Chagas disease: a neglected tropical disease","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-030-44054-1_13","volume-title":"Chagas disease: a parasitic infection in an immunosuppressed host","author":"Shikanai-Yasuda MA","year":"2020"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1469-0691.12585","article-title":"Chagas disease in immunosuppressed host","volume":"20","author":"Lattes R","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1179\/136485907X154629","article-title":"Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV\/AIDS","volume":"101","author":"Sartori AM","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001277","article-title":"Real time PCR in HIV\/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level","volume":"5","author":"Freitas VL","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2011-02-338665","article-title":"Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation","volume":"118","author":"Morgan GJ","year":"2011","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2016-01-693580","article-title":"VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial","volume":"127","author":"Moreau P","year":"2016","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.leu.2401039","article-title":"Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology)","volume":"12","author":"Blad\u00e9 J","year":"1998","journal-title":"Leukemia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie BG","year":"1975","journal-title":"Cancer"},{"key":"ref33","article-title":"Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation","volume":"54","author":"Chalela CM","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-3062.1999.010207.x","article-title":"Reactivation of chronic Chagas\u2019 disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with Benznidazole","volume":"1","author":"Altclas J","year":"1999","journal-title":"Transplant Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-4632.2011.05224.x","article-title":"Reactivation of Chagas\u2019 disease: cutaneous manifestations in two immunosuppressed patients","volume":"51","author":"Riganti J","year":"2012","journal-title":"Int J Dermatol"},{"key":"ref36","first-page":"542","article-title":"Reactivation of Chagas disease after a bone marrow transplant in Italy: first case report","volume":"10","author":"Angheben A","year":"2012","journal-title":"Blood Transfus"},{"key":"ref37","first-page":"46","article-title":"Relato de novos casos de transmiss\u00e3o da Doen\u00e7a de Chagas por transfus\u00e3o de sangue","volume":"10","author":"Amato Neto V","year":"1968","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0004-282X1969000100005","article-title":"Mol\u00e9stia de chagas cr\u00f4nica associada a leucemia linf\u00e1tica: ocorr\u00eancia de encefalite aguda como altera\u00e7\u00e3o do estado imunit\u00e1rio","volume":"27","author":"Fran\u00e7a LC","year":"1969","journal-title":"Arq Neuro-Psiquiatr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0037-86821974000200009","article-title":"Parasitismo incomum do mioc\u00e1rdio e do es\u00f4fago em chag\u00e1sico cr\u00f4nico, portador de doen\u00e7a de Hogkin e uso de imunodepressores","volume":"8","author":"Almeida HO","year":"1974","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/1097-0142(19820901)50:5<827::AID-CNCR2820500503>3.0.CO;2-#","article-title":"Reactivation of Chagas\u2019 disease during therapy of acute lymphocytic leukemia","volume":"50","author":"Kohl S","year":"1982","journal-title":"Cancer"},{"key":"ref41","first-page":"228","article-title":"Reactivation of Chagas\u2019 myocarditis during therapy of Hodgkin\u2019s disease","volume":"43","author":"Metze K","year":"1991","journal-title":"Trop Geogr Med"},{"key":"ref42","first-page":"435","article-title":"Reagudiza\u00e7\u00e4o de cardite chag\u00e1sica provocando insufici\u00eancia ventricular direita exclusiva","volume":"62","author":"Sim\u00f5es MV","year":"1994","journal-title":"Arq Bras Cardiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jon19966294","article-title":"Chagasic granulomatous encephalitis in immunosuppressed patients: computed tomography and magnetic resonance imaging findings","volume":"6","author":"Di Lorenzo GA","year":"1996","journal-title":"J Neuroimaging"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0036-46651996000400008","article-title":"Tumor-like lesion due to Chagas\u2019 disease in a patient with lymphocytic leukemia","volume":"38","author":"Salgado PR","year":"1996","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trstmh.2005.07.005","article-title":"Reactivation of Chagas\u2019 disease in a patient with non-Hodgkin\u2019s lymphoma: gastric, oesophageal and laryngeal involvement","volume":"100","author":"Rezende RE","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/S1516-84842010005000080","article-title":"Reativa\u00e7\u00e3o da doen\u00e7a de Chagas com envolvimento do sistema nervoso central durante tratamento de linfoma n\u00e3o Hodgkin","volume":"32","author":"Oliveira LR","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.rce.2014.04.006","article-title":"Chagas disease reactivation in a patient non-Hodgkin\u2019s lymphoma","volume":"214","author":"Vicco MH","year":"2014","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv060","article-title":"Reactivation of Chagas disease in a patient with follicular lymphoma diagnosed by means of quantitative real-time polymerase chain reaction","volume":"2","author":"Garz\u00f3n MI","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"ref49","author":"Shikanai-Yasuda MA","year":"2022"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4269\/ajtmh.20-1141","article-title":"An evaluation of the use of real-time quantitative polymerase chain reaction to measure levels of Trypanosoma cruzi parasitemia in HIV patients in Cochabamba, Bolivia","volume":"105","author":"Reimer-McAtee MJ","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actatropica.2007.05.019","article-title":"Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples","volume":"103","author":"Pir\u00f3n M","year":"2007","journal-title":"Acta Trop"},{"key":"ref52","series-title":"Gu\u00edas para la atenci\u00f3n al paciente infectado con Trypanosoma cruzi (enfermedad de Chagas)"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico F","year":"2021","journal-title":"Lancet Infect. Dis"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00439-20","article-title":"New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: clinical, parasitological and serological assessment after three years of follow up","volume":"64","author":"\u00c1lvarez MG","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652024000100400&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:59:59Z","timestamp":1707127199000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652024000100400&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":54,"alternative-id":["S0036-46652024000100400"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202466010","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e10"}}